Get the Stockscreener App
34.71
3.89%
1.30
After Hours:
34.97
0.26
+0.75%
Hims Hers Health Inc stock is traded at $34.71, with a volume of 17.22M.
It is up +3.89% in the last 24 hours and down -11.45% over the past month.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
See More
Previous Close:
$33.41
Open:
$33.96
24h Volume:
17.22M
Relative Volume:
0.77
Market Cap:
$7.90B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
50.30
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
+1.79%
1M Performance:
-11.45%
6M Performance:
-27.66%
1Y Performance:
+30.34%
1-Day Range:
$33.19
$35.83
1-Week Range:
$32.05
$35.83
52-Week Range:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
34.71 | 7.61B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
129.37 | 55.49B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.69 | 49.35B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.53B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.00 | 35.51B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
489.69 | 21.39B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Oct-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers enters 2026 on solid ground — stock rises even after Novo Nordisk leaves it off Wegovy partner list - MSN
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List - Stocktwits
Best Healthcare Stocks To ConsiderJanuary 5th - MarketBeat
How strong is Hims Hers Health Inc stock revenue growthJuly 2025 Review & Stock Market Timing Techniques - moha.gov.vn
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization - Yahoo Finance UK
Hims & Hers: A Great Moment To Buy The Dip (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc. Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative
Promising Healthcare Stocks To Keep An Eye OnJanuary 4th - MarketBeat
Healthcare Stocks To ConsiderJanuary 1st - MarketBeat
Promising Healthcare Stocks To ConsiderJanuary 3rd - MarketBeat
Hims & Hers Health (NYSE:HIMS) Seems To Use Debt Rather Sparingly - simplywall.st
Best Healthcare Stocks To Watch NowJanuary 2nd - MarketBeat
The Biomarker Blood Testing Gold Rush Is Here - Athletech News
HIMS Stock On A Losing Spree: Here's Why - Forbes
Market Sentiment Sours for Hims & Hers Shares - AD HOC NEWS
Mixed options sentiment in Hims and Hers Health with shares down 2.47% - Yahoo Finance
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid - Finviz
HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns - Trefis
How Hims & Hers Health Inc. Class A (HIMS) Affects Rotational Strategy Timing - Stock Traders Daily
Best Healthcare Stocks Worth WatchingDecember 28th - MarketBeat
Healthcare Stocks To Watch TodayDecember 31st - MarketBeat
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus - ts2.tech
Hims & Hers Faces Investor Scrutiny Amid Profitability Concerns - AD HOC NEWS
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Notable Tuesday Option Activity: Z, UPS, HIMS - Nasdaq
Best Healthcare Stocks To Watch TodayDecember 30th - MarketBeat
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - Yahoo Finance
Hims Delivered 173% Returns Over Five Years but Recent Buyers Face 50% Losses - AOL.com
Hims & Hers Health (HIMS) Fell Due to Increased Regulatory Challenges - Insider Monkey
Hims & Hers Health Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative
Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga
TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside - Finviz
Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar - ts2.tech
Returns Recap: Why hedge funds are buying Hims Hers Health Inc stockBuy Signal & Expert Approved Momentum Ideas - moha.gov.vn
Hims & Hers: A Growth Story Battling Market Skepticism - AD HOC NEWS
Carnegie Investment Counsel Acquires 61,560 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Top Healthcare Stocks To Follow TodayDecember 23rd - MarketBeat
How Do Investors Really Feel About Hims & Hers Health Inc? - Benzinga
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Why Hims & Hers Health, Inc. (HIMS) Went Up On Wednesday? - MSN
Assessing Hims and Hers After Its 462% Multi Year Surge and Premium Valuation Multiple - Yahoo Finance
HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? - Finviz
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking - Stocktwits
Hims & Hers Health Stock (HIMS) Opinions on Recent Volatility and Expansion - Quiver Quantitative
Voya Investment Management LLC Buys 52,370 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers quietly scooped up nearly 300,000 square feet in East Valley - The Business Journals
New Albany gains $200M health care expansion, 400 new jobs - Yahoo
Oluyemi Okupe Sells 23,090 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):